COVID-19 relapse: a diagnostic predicament for clinicians
- Shramana Deb,
- Gourav Shome,
- Ritwick Mondal,
- Durjoy Lahiri
Shramana Deb
S.N. Pradhan Centre for Neuroscience, University of Calcutta, India
Corresponding Author:shramanadeb1995@gmail.com
Author ProfileRitwick Mondal
Institute of Postgraduate Medical Education and Research Bangur Institute of Neurology
Author ProfileDurjoy Lahiri
Institute of Postgraduate Medical Education and Research Bangur Institute of Neurology
Author ProfileAbstract
Abstract- The ongoing outbreak of COVID-19 that began in Wuhan, China,
has constituted a Public Health Emergency of International Concern, with
cases confirmed in more than 200 countries. Currently, infected
individuals are the primary source of infection and multiple cases of
relapse are also reported following the recovery. It is highly
concerning about the nature of relapse which may be caused due to
reactivation or reinfection. While the present testing scenario of using
different molecular techniques has several loop holes that can report
false results and hamper the process of effectively preventing the
transmission of the virus. Various recommendations need modifications as
to effectively stop the horizontal transmission of the virus and look
deeply into the links with relapse cases to prevent a second wave during
a pandemic.